Venture Capital News Daily
   Your Source for Venture Capital and Private Equity Financings
   Massinvestor/VC News Daily      
   Venture Capital News Daily on RSS Venture Capital News Daily on Facebook Venture Capital News Daily on Twitter
VC Directories Mobile Apps Celebrity VCs VentureTrackr Archive About Us
VC-funded Company:

909 Fannin Street, Suite 2100
Houston, TX 77024
Phone: 206-805-1600

OncoResponse mines the human adaptive immune system to discover therapeutic antibodies against novel immuno-oncology targets. By identifying candidates from the immune systems of patients who have responded exceptionally well to cancer immunotherapies, OncoResponse has the potential to increase the success rate of these therapies across multiple cancer types.

Key Contact
Clifford J.

Funding Events
05/26/16undisclosedSeries A Baxalta Ventures
03/10/17$22,500,000Series A Alexandria Real Estate Equities
ARCH Venture Partners  
Canaan Partners  
HT Family Office
MD Anderson  
Rice University
Massinvestor/VC News Daily

© 2017 Massinvestor, Inc.